AZN-OLD
AstraZeneca PLC
AstraZeneca PLC historical holders
total: 6
Viking Global Investors AstraZeneca PLC transactions over time
- Total transactions:
- 3
- New positions:
- 1
- Sold out:
- 1
- Reduced:
- 1
- Held since:
- 2016 Q3
- Held for:
- 2 quarters
- Latest activity:
- 2017 Q1
Ole Andreas Halvorsen has been an institutional investor in AstraZeneca PLC (AZN-OLD) since 2016 Q3. According to 2026 Q1 report, Ole Andreas Halvorsen doesn't hold any shares. The fund/company first acquired AZN-OLD in 2016 Q3, initially purchasing about 4.18M shares. Since the initial investment, Viking Global Investors has made 2 more transactions in this position.
When did Ole Andreas Halvorsen exit their AZN-OLD position?
Ole Andreas Halvorsen no longer holds AstraZeneca PLC (AZN-OLD). They sold off their entire position in 2017 Q1, closing out an investment that began in 2016 Q3.
When did Ole Andreas Halvorsen first invest in AZN-OLD?
Ole Andreas Halvorsen first invested in AstraZeneca PLC (AZN-OLD) in 2016 Q3 at the reported quarter-end price of $32.86 per share, acquiring 4,175,587 shares in their initial purchase.
What is Ole Andreas Halvorsen's average cost basis for AZN-OLD?
Based on historical transaction data, Ole Andreas Halvorsen's estimated cost basis for AstraZeneca PLC (AZN-OLD) is approximately $32.86 per share. This represents their average reported price* across all buy transactions.
Estimated cost basis*
- Weighted AVG buy price:
- $32.86
- Weighted AVG sell price:
- $27.32
AZN-OLD transactions history by Viking Global Investors
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.